Longeveron Inc. (LGVN)
After hours:
| Previous Close | 1.7400 |
| Open | 1.7800 |
| Bid | 1.7800 x 200 |
| Ask | 1.8200 x 200 |
| Day's Range | 1.7000 - 2.0799 |
| 52 Week Range | 1.6000 - 44.0000 |
| Volume | |
| Avg. Volume | 2,142,776 |
| Market Cap | 8.684M |
| Beta (5Y Monthly) | 0.20 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -10.2000 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 14.05 |
GlobeNewswireLongeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
MIAMI, May 02, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will report first quarter 2024 financial results and provide a business update on Tuesday, May 14, 2024 after the U.S. financial markets close. The Company will host a conference call and webcast the same day at 5:00 p.m. ET. Conference Call Details: Conference Call Number: 1.877.407.0789 Conference ID: 13745868 Call meTM Featur
- ACCESSWIRE
Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 30 - May 2, 2024, where 96 MicroCap public and private companies will be presenting at the Paris Hotel & Casino in Las ...
- GlobeNewswire
Longeveron to Present at the Planet MicroCap Showcase
MIAMI, April 25, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will participate in the Planet MicroCap Showcase, taking place May 1-2, 2024. Details for the Company’s presentation: Date:Wednesday, May 1, 2024 Time:4:30 p.m. PT Webcast:Click Here An archived replay of the webcast will be available on the “Events & Presentations” section of the Company’s website following the conference. If
